Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case

This article describes a case of successfully used tocilizumab (interleukin 6 receptors monoclonal antibodies) in a two-year patient with severe systemic juvenile idiopathic arthritis resistant to oral and parenteral glucocorticoids, nonsteroidal anti-inflammatory drugs, and methotrexate. Just after...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: E. I. Alekseeva, S. I. Valieva, T. M. Bzarova, R. V. Denisova, T. V. Sleptsova, O. L. Lomakina, A. M. Chomakhidze
Format: Artigo
Jezik:Inglês
Izdano: Paediatrician Publishers, LLC 2016-11-01
Serija:Pediatričeskaâ Farmakologiâ
Teme:
tocilizumab
juvenile idiopathic arthritis
children
Online pristup:https://www.pedpharma.ru/jour/article/view/1447
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items